ERBIN and cholangiocarcinoma: Similarly, TILs from cholangiocarcinoma patients containing Th1 CD4+ subsets recognize a cancer-expressed mutated erbb2-interacting protein (ERBB2IP), as shown by the whole-exome-sequencing-based approach.